Browse Subject Areas

Click through the PLOS taxonomy to find articles in your field.

For more information about PLOS Subject Areas, click here.

  • Loading metrics

Frequent Missense and Insertion/Deletion Polymorphisms in the Ovine Shadoo Gene Parallel Species-Specific Variation in PrP

  • Nathalie Daude,

    Affiliation Centre for Prions and Protein Folding Diseases, University of Alberta, Edmonton, Alberta, Canada

  • Serene Wohlgemuth,

    Affiliation Centre for Prions and Protein Folding Diseases, University of Alberta, Edmonton, Alberta, Canada

  • Ekaterina Rogaeva,

    Affiliation Centre for Research in Neurodegenerative Diseases, University of Toronto, Toronto, Ontario, Canada

  • A. Hossein Farid,

    Affiliation Department of Animal Science, Nova Scotia Agricultural College, Truro, Nova Scotia, Canada

  • Mike Heaton,

    Affiliation United States Department of Agriculture, U. S. Meat Animal Research Center, Clay Center, Nebraska, United States of America

  • David Westaway

    Affiliation Centre for Prions and Protein Folding Diseases, University of Alberta, Edmonton, Alberta, Canada

Frequent Missense and Insertion/Deletion Polymorphisms in the Ovine Shadoo Gene Parallel Species-Specific Variation in PrP

  • Nathalie Daude, 
  • Serene Wohlgemuth, 
  • Ekaterina Rogaeva, 
  • A. Hossein Farid, 
  • Mike Heaton, 
  • David Westaway



The cellular prion protein PrPC is encoded by the Prnp gene. This protein is expressed in the central nervous system (CNS) and serves as a precursor to the misfolded PrPSc isoform in prion diseases. The prototype prion disease is scrapie in sheep, and whereas Prnp exhibits common missense polymorphisms for V136A, R154H and Q171R in ovine populations, genetic variation in mouse Prnp is limited. Recently the CNS glycoprotein Shadoo (Sho) has been shown to resemble PrPC both in a central hydrophobic domain and in activity in a toxicity assay performed in cerebellar neurons. Sho protein levels are reduced in prion infections in rodents. Prompted by these properties of the Sho protein we investigated the extent of natural variation in SPRN.

Principal Findings

Paralleling the case for ovine versus human and murine PRNP, we failed to detect significant coding polymorphisms that alter the mature Sho protein in a sample of neurologically normal humans, or in diverse strains of mice. However, ovine SPRN exhibited 4 missense mutations and expansion/contraction in a series of 5 tandem Ala/Gly-containing repeats R1-R5 encoding Sho's hydrophobic domain. A Val71Ala polymorphism and polymorphic expansion of wt 67(Ala)3Gly70 to 67(Ala)5Gly72 reached frequencies of 20%, with other alleles including Δ67–70 and a 67(Ala)6Gly73 expansion. Sheep V71, A71, Δ67–70 and 67(Ala)6Gly73 SPRN alleles encoded proteins with similar stability and posttranslational processing in transfected neuroblastoma cells.


Frequent coding polymorphisms are a hallmark of the sheep PRNP gene and our data indicate a similar situation applies to ovine SPRN. Whether a common selection pressure balances diversity at both loci remains to be established.


Prion diseases (also known as Transmissible Spongiform Encephalopathies, “TSE”s) are a group of fatal neurodegenerative diseases that include Creutzfeldt-Jakob disease (CJD), scrapie and bovine spongiform encephalopathy (BSE) in human, sheep and cattle, respectively [1]. The pathological hallmarks of these diseases include spongiform change of the neuropil and accumulation of misfolded forms (“PrPSc”, PrP-scrapie or “PrPD” to denote PrP-disease) of the cellular prion protein (PrPC), with some but not all aggregates being visible by light microscopy in the form of amyloid deposits detected with intercalating dyes or PrP-directed antibodies [2]. Non-conserved missense mutations and insertions that affect the PRNP gene, which encodes the PrP protein, are associated with inherited human prion diseases. Moreover, polymorphisms at codon 129 (the major polymorphic site of the PRNP gene, present in many ethnic groups) influence susceptibility to the disease as well as the age of onset, clinical phenotype and the duration of the illness [3]. Genetic control of prion disease has also been demonstrated in animals. For example, missense polymorphisms in sheep at codons 136, 154 and 171 are strongly correlated with disease susceptibility and progression in animals affected by natural scrapie or experimental scrapie disease caused by administration of infectious inocula [4][7]. Sheep PRNP alleles conferring heightened susceptibility to natural scrapie disease may improve postnatal survival [8], offering a parallel to the literature defining neuroprotective properties for PrPC, and perhaps explaining the paradox of their retention in commercial stocks.

In addition to the obvious importance of the PRNP gene in modulating prion diseases, there are clinical and experimental findings that demonstrate that other factors play a role in disease pathogenesis. Recently, a gene denoted SPRN, coding for the protein Shadoo (Sho) has been identified as a new CNS-expressed member of the prion protein superfamily, a family now currently comprising PrP, Doppel and Sho [9]. Sho, like PrP, is GPI-anchored, N-glycosylated and endoproteolytically processed to a “C1” fragment. In a cerebellar granule cell assay, Sho has neuroprotective properties and is a plausible candidate for the hypothetical PrPC-like protein π (‘pi’) deduced from the phenotypic properties of PrP null (Prnp0/0) and ΔPrP transgenic mice [10], [11]. Moreover, Sho protein levels are profoundly reduced in the brains of prion-infected rodents [11]. Thus, a detailed analysis of SPRN in different populations may be informative in determining its importance in physiology, and ultimately in the case of prion disease. Here we assess polymorphisms of SPRN in human and sheep populations, and inbred mouse strains. Our data define species-dependent levels of polymorphic variation and reveal potential DNA instability in the centre of the ovine SPRN coding sequence.

Materials and Methods

DNA samples

Mouse (Mus Musculus) DNA samples represent a panel of strains commonly used in a research laboratory. The different strains are: Swiss lineage (SWR/J, SJL/J, FVB/NCR), Castle's lineage (LP/J, 129S6, VM/DK, DBA/IJ, C3H/He SnJ, CBA/NJ, NZB/BinJ, NZW/lacJ, MA/MyJ, P/J), C57 lineage (C57l/J, C58/J), wild lineages (Molf/Ei, Cast, IS/Cam). Other lineages include RIIIS/J, RIII/DM, LG/J, and JE/Le, while Mus Spretus represents a related species. Sheep DNA samples were selected from DNA banks from Canadian and American sheep breeds. In addition to 10 two-generation unrelated sheep from North Country and Border Cheviots from different farms in British Columbia and Nova Scotia, the USMARC Sheep Diversity Panel version 2.4 (MSDP2.4) was used. The latter consists of samples from 96 rams representing nine popular US breeds of sheep and one Navajo-Churro ram. The latter ram was included because it has a rare A136, R154, K171 PRNP genotype. The nine major breeds are divided into four classifications: 1) general purpose breeds including Dorset, Rambouillet, and Texel; 2) terminal-sire breeds including Suffolk and Composite (1/4 Suffolk, 1/4 Hampshire, and 1/2 Columbia); 3) prolific breeds including Finnsheep and Romanov; and 4) hair-shedding breeds including Dorper and Katahdin. The sires within breeds were selected for minimal relationships within and between pedigrees. The samples were collected between 1997 and 2003 from rams that were two to five years old. Unrelated human DNA samples (n = 93) were collected in Toronto, have a predominantly Northern European origin, and were from individuals neurologically normal at the time of blood collection. Written informed consent for research purposes, approved by the University of Toronto research ethics board, was obtained from all individuals involved in the study.

Cloning of a 4 kb sheep SPRN fragment

The forward primer (SF1, Table S1) was designed upstream of the bovine open reading frame (ORF) of SPRN and the reverse primer (SR1, Table S1) was designed downstream of the sheep MGT1 sequence using the software Primerselect™ (Figure 1). Primer pairs were checked for hairpin and duplex formation and synthesized by Integrated DNA Technologies (Coralville, USA). PCR was performed in 25 µl volume containing 1 µM dNTPs, 0.2 µM of each primer, 5% DMSO, 1X reaction buffer and 1U of Accuprime™ Taq DNA polymerase (Invitrogen). Thermal cycling was performed on a Mastercycler® ep (Eppendorf) with a silver heating block, with the protocol: (1) 96°C for 5 min, (2) 25 cycles of 96°C for 30 s, 58°C for 30 s, and 72°C for 5 min, (3) 72°C for 10 min. PCR products were electrophoresed on agarose gels and visualized by SYBR® green staining and ultraviolet transillumination. For analysis of insertion/deletion (in/del) variations PCR products were analyzed on 15% (29∶1 acrylamide; bis-acrylamide) polyacrylamide gels run in 50 mM Tris-Borate EDTA buffer.

Figure 1. Overview of SPRN genes.

(A) Consensus chromosomal structure of mammalian SPRN deduced from mouse and human prototypes: SPRN is flanked by the Olfr322 and Mtg1 genes. Oligonucleotide primers SF1 and SR1 used to amplify sheep SPRN sequences were deduced from this consensus structure. Panels B and C (not to same scale as Panel A) represent mRNAs encoding Human (B) and (C) sheep SPRN. Light grey boxes 1 and 2 represent the exons. The entire ORF (dark grey) of SPRN is located on exon 2. The common polymorphisms discussed in the main text are represented, as well as the indel variations (not to scale) in ovine SPRN.

Amplification of SPRN open reading frames

Primers used to amplify the mouse (MF1 and MR1), sheep (SF2 and SR2) and human (HF1 and HR1) (Table S1) ORFs were designed as previously described. The entire sheep ORF was amplified using the protocol: (1) 96°C for 5 min, (2) 35 cycles of 96°C for 30 s, 62°C for 30 s, and 72°C for 1 min, (3) 72°C for 10 min. For amplification of the mouse and human ORF chain elongation were extended to 90 sec.

Sequencing and Bioinformatics

SPRN polymorphisms were detected by automated DNA sequencing and analysed by capillary electrophoresis on an ABI Prism 3730 DNA Analyzer (Applied Biosystems, Foster City, CA, USA). The sequencing primers, MF1, MR1, HF2, HR2, SF2 and SR2 (Table S1), were used for the mouse, human and sheep samples respectively. The reaction was set up according to the manufacturer's protocol using ‘Big Dye’ terminator chemistry. A final concentration of 5% DMSO and 1M betaine was added to the reaction mix to reduce potential secondary structure (because the high GC content of SPRN: see main text). Data were analysed using SeqMan™ software. When necessary (see main text), some PCR amplified samples were sub-cloned into pCR2.1 TOPO vector (Invitrogen) to confirm the chromosomal phase of nucleotide polymorphisms. The sheep genome database was interrogated with ISGC BLAST using the most current assembly.

Expression of Sho plasmids in N2a neuroblastoma cells

The sheep Sho open reading frames (ORFs) of the alleles A71, V71, “+9”, and “−12” were amplified by PCR with primers SF3 and SR3 (Table S1) and cloned into the HindIII and XbaI sites of pBUD.CE4 also expressing GFP from a second promoter (Invitrogen). Sho mutants were generated using previous methods [12] with constructs verified by DNA sequencing. N2a cells were cultured, transfected and lysed as previously described [12]. 24 hours post-transfection, cells were treated with 35 µg/ml cycloheximide for 2 to 8 hours. 50 µg of total protein were treated by PNGaseI (New England Biolabs) for 4 hours. Protein was separated by SDS–PAGE using 12% polyacrylamide gels and transferred to nitrocellulose (5% non-fat skim milk block). Blots were incubated overnight with primary antibodies (06rSH-3a Sho polyclonals [11] or anti-GFP (Clontech) monoclonal, at 1∶1000 and 1∶500 respectively), incubated with HRP-conjugated secondary antibody and then developed using ‘Western Lightning’ ECL (Perkin-Elmer).


Mouse SPRN polymorphisms

Genomic DNA from 22 diverse mice strains (see Materials and Methods) was examined for polymorphisms in the SPRN open reading frame. 22 samples did not present any polymorphisms and were thus similar to the published sequences (GI:56118240), and in agreement with NCBI SNP database entries available at time of writing. One further sample from wild sprettus mouse, comprising a different species from Mus musculus [13], exhibited polymorphisms (A/G at position 33, G/A at position 324 and T/C at position 408). Although these polymorphisms do not result in changes in the corresponding amino acids (Leu, Gly and Gly at codons 11, 108 and 136, respectively), a fourth polymorphism at position 400 (T/C) does results, in an amino acid change, L134F in the GPI attachment signal peptide.

Human SPRN polymorphisms

Genomic DNA from 93 healthy human subjects was examined for polymorphisms in the uninterrupted SPRN open reading frame (Table 1). By virtue of i) selective primers, ii) the size of the PCR product used for sequencing reactions, and iii) the nature of the retrieved sequences we could absolutely assign these sequences to the authentic SPRN ORF and not the degenerated ORF of the SPRN pseudogene located 160 kb distally [14]. At position −11 relative to the start codon of the human SPRN gene, 35 subjects (37.6%) were genotyped as A/A, 14 subjects (15.1%) as G/G, and 44 subjects (47.3%) as A/G. The allele frequency is 62% for A. Two polymorphisms were identified in the ORF. The first causes the amino acid change T7M in the N-terminal signal peptide and is common, while a less frequent second polymorphism at codon 61 is silent. These two polymorphisms had previously been identified in the human single nucleotide polymorphism (SNP) database as rs 2492666 and rs 4077586, respectively. At nucleotide position 20 of the ORF (codon 7, signal peptide) the C allele reaches a frequency is 35% while a silent polymorphism at nucleotide position 183 (codon 61, T nucleotide) reaches a frequency of 29% (Table 1). In sum, these data indicate a paucity of human missense polymorphisms affecting the mature Sho protein (i.e., the region that remains subsequent to endoproteolytic processing to remove the N- and C-terminal signal peptides).

Cloning the ovine SPRN gene

While human SPRN sequences were available from genomic databases, an anchored PCR cloning strategy was employed to retrieve a prototype of the sheep SPRN gene. This strategy was based upon (i) the assumption that the ORF and the extended flanking regions would be highly conserved between cattle and sheep and (ii) a published sequence for the sheep MTG1 gene, a gene that lies immediately adjacent (3′) to SPRN in other mammals. Thus, the bovine SPRN genome sequence was used as a template to design the forward primers to amplify the homologous region in sheep, with reverse primers deriving from the sheep MTG1 sequence (Figure 1A). The resulting 3352 bp fragment of sheep SPRN was amplified, cloned and sequenced. Prior to the publication of this work a sequence similar to the wt sheep SPRN sequence was published by Lampo et al [Genbank (gi|145688401)[15]]. However this sequence deviates from the common prototype in sheep and other mammals in that it contains an additional 6 nucleotides and does not represent the most prevalent allelic type in our sample set. It also does not correspond to the number of unit repeats found in the wt SPRN genes of other mammalian species (discussed below).

Common SNPs and trinucleotide indels in the ovine SPRN gene

Data overview.

A total of 107 DNA samples from healthy sheep were analyzed for SPRN polymorphisms. The samples were derived from two complementary sources. First, a panel of DNAs from a purebred stock of Cheviot, this breed being selected because it was the source for a wide variety of scrapie isolates deriving from the so-called “SSBP/1” inoculum [16]. The second source was from a pre-assembled “diversity panel” designed to represent the breadth of genotypic variation within the US sheep industry, comprising ten purebred sheep breeds and also a “composite” stock derived from interbreeding of Suffolk (1/4), Hampshire (1/2) and Columbia (1/4) breeds. Deduced allele types and genotype frequencies for the sheep SPRN gene are summarized in Tables 24, and in Figures 1 and 2. In overview we found that the sheep SPRN coding region exhibits a variety of coding polymorphisms (see Tables 2). These polymorphisms fall into two broad categories. The first category corresponds to missense changes throughout the coding region, the most prevalent being V71A, and the second category to a series of in-frame trinucleotide indel variations in the vicinity of codon 70. Along with silent nucleotide replacements, the common nucleotide variations polymorphisms could be arranged into at least 15 coding region haplotypes as deduced by direct sequencing of PCR amplified DNA and also by cloning and sequencing of individual PCR products from certain heterozygous animals (Figures 1, 2).

Figure 2. Sheep SPRN coding region haplotypes.

Representation of the major coding region haplotypes observed in common sheep breeds. a and b, putative wild type ancestral haplotype and silent Y112Y polymorphism with a C residue in this codon, respectively; c, d, 6 bases insertion variants (solid fill triangle) of a and b, respectively: e, “−12” nucleotide deletion haplotype (open triangle); f haplotype encoding alanine at codon 71 and g same with silent Y112Y polymorphism with a C residue in this codon. Haplotypes h to o comprises less common variants represented by 3 or fewer animals.

Table 3. Overall frequencies of single nucleotide polymorphisms of sheep SPRN.

Missense polymorphisms of ovine SPRN

Overall, we found two frequent single base-pair polymorphisms, in codons 71 and 112 (V71A and Y112Y). There were 3 rare missense polymorphisms present in 5 or fewer alleles of the total sample of 214 alleles (Table 3: G21S, A53P, H126P), and also a fourth silent polymorphism G132G. Note that the codon numbering scheme used here and below is based upon our establishment of the most frequent “a” allele of SPRN as a likely prototype of the ancestral ovine sequence (Genbank #EU380591).

Prevalent SNPs.

With regards to the common SNPs, for codon 71 a total of 87 sheep (81.3%) were genotyped as T/T at nucleotide 212 (Val/Val), 3 sheep (2.8%) as C/C (Ala/Ala), and 17 sheep (15.9%) as C/T heterozygotes, with representative electropherograms of V71, A71 and V71/A71 heterozygotes presented in Figure 3A. The allele frequency for the T polymorphism is thus 89.3%. At nucleotide position 336 (silent polymorphism within codon 112), 52 sheep (48.6%) were genotyped as T/T, 19 sheep (17.8%) as C/C, and 36 sheep (33.6%) as C/T, giving an allele frequency of 65.4% for the T polymorphism. These data contribute to the assignment of V71(T) – Y112 (T) as the most common haplotype, SPRNa, and V71(T) – Y112 (C) as the second most prevalent (SPRNb: Figure 2).

Figure 3. Sequences of Different Sheep SPRN alleles.

(A) Electrophoregrams presenting the polymorphism V71A. Codon 71 is either GTA (Val) or GCA (Ala). (B) Electrophoregrams of sequencing reactions from cloned PCR products, representing a deletion of 12 bases, or insertions of either 6 or 9 bases relative to the wild type prototype.

Rare SNPs.

With regard to less frequent variations, one Katahdin sheep was heterozygous A/G at nucleotide 61 defining an S21 sub-variant of SPRNc (i.e. one occurrence out of 214 alleles sampled; haplotype “i”, Figure 2). Three Cheviot sheep were heterozygous G/C at nucleotide 157. Inspection of co-inherited SNPs in codons 71 and 112, as well as cloning of individual PCR products defining a P53 sub-variant of SPRNb (i.e. three occurrences out of 214 alleles sampled; haplotype j and k, Figure 2). Three sheep (one Rambouillet, one Suffolk, one Katahdin) exhibited a missense C variation at nucleotide 377, H126P (haplotype m, Figure 2). The two former animals were homozygous C/C and the Katahdin was heterozygous (i.e. five occurrences out of 214 alleles sampled). All data from sequencing of bulk PCR products and cloning of individual PCR-amplified alleles are consistent with this SNP representing a sub-variant of SPRNa. The last rare variant, a silent T polymorphism at nucleotide 396 (G132G) was represented by 3 heterozygous animals (one Cheviot, two Katahdin; i.e. 3 occurrences out of 214 alleles; haplotypes n and o, Figure 2), with all data from sequencing of bulk PCR products and cloning of individual PCR-amplified alleles being consistent with this rare SNP representing a sub-variant of SPRNb. Thus the rare variant sighted most often (5/214 alleles) occurs in the framework of SPRNa, the predominant haplotype and the prototype for the ancestral ovine SPRN sequence.

Common Indel variations affecting the hydrophobic domain of ovine Sho

Direct sequencing of amplified ovine genomic DNA revealed a number of samples with unusual electropherograms (not shown), wherein coherent sequence data diverged into a “mixed” output comprising two co-existing sequences. We inferred these data to be consistent with a common size variation in the length of the ovine SPRN ORF, with animals with mixed sequence electropherograms representing heterozygotes for size variation, and the boundary between coherent and mixed sequence in the electropherogram representing the boundary of the indel heterozygosity. This inference of genic size variation was confirmed in two ways. First, genomic DNA PCR products of the complete SPRN ORF were digested directly with Ava1 endonuclease to generate restriction fragments amenable to PAGE sizing. Representative analyses are shown in Figure 4. In contrast to invariant fragments of 252 and 204 nucleotides (nt) lying outside of the polymorphic region, size variation polymorphism was noted in smaller fragments corresponding to larger (“+6nt: and “+9nt”) and smaller (“−12nt”) variations from a wt restriction fragment length of 130 base-pairs. Secondly, we cloned and sequenced individual PCR products from 7 animals differing from the wt point of reference (established from allele frequency and alignment of multiple mammalian species), both to confirm the observation and to pinpoint the identity of the nucleotide variations. These data are shown in Figure 3B and can be explained in terms of expansion or deletion of nucleotides encoding a tract of hydrophobic amino acids in the centre of the protein. The prototype tract in the wt sequence commences after Arg58 and corresponds to three contiguous repeats (R1-R3) of the sequence Ala-Ala-Ala-Gly, a fourth polymorphic repeat R4 either Val-Ala-Ala-Gly or Ala-Ala-Ala-Gly, and a fifth degenerate repeat R5, Leu-Ala-Ala-Gly. Thus this central region of wt ovine Sho can be described in single letter code (starting at residue 54) by …GSSVR-[R1, R2, R3, R4, R5]-SSWR…

Figure 4. Detection of an Indel variation in the sheep SPRN open reading frame.

Samples DNAs were amplified by PCR, digested with AvaI, and run on 15% PAGE gels. AvaI digestion generates 3 fragments: 251 bp, 204 bp, and variable sizes for the smaller fragments, corresponding to 118, 130, 136 and 139 bp respectively for “−12nt”, wild type, “+6nt” and “+9nt” allelic variants. M: Molecular weight marker.

To assign the start and stop points in variants of this repeated sequence we compared the nucleotide sequences of repeats:where the position of the valine in the V71A polymorphism is underlined. Whereas R1, R4, and R5 have unique nucleotide sequences, R2 and R3 are identical and thus cannot be distinguished from each other unless they occur together and are flanked by R1 and R4. The observed sequence variations in ovine SPRN alleles are all compatible with alterations within or adjacent to R3, represented as follows:

Thus in this scheme the “−12nt” variant corresponds to Δ67–70 (Genbank #EU380592). The “+6nt” sequence reported here and previously by Lampo et al, corresponds to insertion of two extra alanine codons to make a variant (Ala)5Gly repeat, and the “+9nt” sequence adds yet one more alanine codon to make a (Ala)6Gly variant of the (Ala)3Gly repeat prototype (Genbank #EU380590).

Frequency and breed distribution of ovine SPRN indel variants.

Using the above classification scheme in conjunction with genotyping by PAGE analysis of digested amplified DNA, and by cloning of individual PCR products we assessed the frequency of the indel variants in the sample of 214 ovine SPRN alleles. The sequence with four (Ala)3Gly repeats was most prevalent, with 166 occurrences (78%), in close agreement with the situation for wt alleles in other mammals (Figure 5, Table 4). On the other hand, one quarter of all sheep alleles sampled had expansions or contractions in this region: 43 occurrences (20%) of “+6nt” variants, 4 occurrences of “–12nt” variants, and a single occurrence of a “+9nt” variant (Table 4). Breed distribution was assessed for the most common “+6nt” variant, but all breeds were found to include at least one heterozygote. For the rare indel alleles the sample size was insufficient to impart statistical power and here we merely note that the “+9nt” variant occurred in the single Navajo-Churro animal tested, and that 3 out of 4 of the “–12nt” polymorphisms occurred in Finn animals, with the fourth in the “composite” (Suffolk-Hampshire-Columbia) stock (Table 2).

Figure 5. Alignment of Sho proteins.

(A). Alignment of amino acid sequences (Clustal W) of the central regions of diverse Sho proteins. The hydrophobic domain area including amino acids 48 to 82 (according to the wild type sheep numbering) is presented. The four perfect (Ala)3Gly repeats are indicated underneath the sequences with open block arrows, while a fifth, degenerate repeat Leu(Ala)2Gly is indicated by a grey arrow. (B) Alignment of the sheep indel polymorphisms affecting the hydrophobic domain. For clarity, the wt sheep sequence is included in both types of alignment.

Relationship of ovine SPRN indel variants to missense polymorphisms.

Presence or absence of indel polymorphisms was used to construct coding region haplotypes (Figure 2). The common “+6nt” polymorphism was present in conjunction with the common missense variation noted above (i.e. T-T, and T-C) where T and C refer to alternative nucleotides in codons 71 and 112 defining the ovine SPRN types a and b (Figure 1, 2). Thus the “+6nt” polymorphism may have arisen independently in the most common SPRN a and b haplotypes to give the corresponding “+6nt versions” (i.e., alleles c and d, respectively), or may have occurred once in an a or a b haplotype, and then been redistributed by a crossover event (discussed in greater detail below). All 4 “–12” polymorphisms identified occurs in framework like the b haplotype (e). Haplotype h was assigned for the single “+9” allele identified to date. Our haplotypes ag constructed by excluding rarer SNPs (as described above) exhibit limited overlaps with haplotypes based upon analysis of Cheviot, Welsh Mountain and undefined “modern” breeds [17]. Specifically, while haplotype a corresponds to haplotype “2”, b to “1”, d to “7”, and f to “11”, haplotypes c, e and g are not represented in the dataset of Stewart et al. Also, and as implied by the nomenclature system applied here, we found the most common haplotype to be haplotype a. and this to correspond to a T residue at nucleotide 336 in the silent polymorphism Y112Y (56% of animals).

Allelic forms of ovine Sho proteins assessed in Neuroblastoma cells

To assess if ovine indel SPRN alleles produce stable proteins or proteins with distinct biochemical properties we performed acute transfections into N2a neuroblastoma cells using a bigenic “pBUD” expression vectors encoding Sho alleles of interest plus a GFP reporter gene driven from a separate promoter. Cycloheximide was added to some samples to prevent de novo protein synthesis. Proteins in cell lysates were assessed by immunoblot with a monospecific ‘06Sh3a’ antiserum [11] raised against a C-terminal peptide epitope in mouse Sho (Figure 6).

Figure 6. Expression and turnover of Sheep Sho alleles in transfected N2a cells.

(A) GFP fluorescent signals in fields of transfected cells to demonstrate similar transfection efficiencies. Individual values were V71 (10.1%), A71 (5.1%), “+9” (8.7%), “−12” (7.1%). (B) Western blot analysis of N2a transfected cells chased for different time periods in the presence of cycloheximide. Proteins samples are de-glycosylated with PNGase F. Positions of full-length and C1 fragments of sheep Sho are indicated, detected with a C-terminal anti-Sho antibody.

To appraise potential confounding effects of variable transfection efficiency, absolute transfection efficiencies were established for each plasmid by robotic cell counting, by comparing the number of nuclei stained with Hoechst dye versus the total number of GFP-positive cells. These experiments failed to reveal differences between the four alleles or the empty vector control expressing just GFP (average 3%, range 2.3 −3.5%: Fig 6a). In accord with these data, robust and similar immunoblot signals for Sho protein were seen in cells transfected with the 4 alleles (Fig. 6b) (prior experiments have demonstrated that Sho immunoreactivity is not detected in untransfected cells [11]). Probing with an antibody against GFP comprised a control for plasmid-based expression and sample loading. Time-point data establish that sheep Sho proteins are similarly labile, with a half-life measured at under 2 hours (compare 0 and 2 hr. measurements). They also establish that sheep Sho protein expressed in N2a cells is subjected to a “C1-like” processing event, irrespective of allelic type. This effect is similar to that seen for mouse Sho, and could prove analogous to the endoproteolytic processing of PrP.


Human and Mouse versus Ovine SPRN

In this study, we assessed polymorphisms of the Sho gene of humans, mice and sheep. We find that mice have little coding sequence variation in this gene, in accord with a recent study based on a different sample set [18]. In the case of human SPRN we confirmed a signal peptide M7T variation was found in our sample of Caucasian DNAs (and as reported previously by others [19]), but we were unable to define a high frequency polymorphism within the boundaries of the mature human Sho protein (residues 24 to 126). While this picture might change with the inclusion of larger sample sizes and samples from different ethnic groups, the compiled NCBI SNP database is also not supportive of a plethora of missense variation within human SPRN, even though this includes samples derived from multiple ethnic groups (HapMap project, including populations that have Asian, African and European origins). Other described human SPRN SNPs comprise a signal peptide polymorphism L13Q and the coding sequence variation G42 (SNPs rs2492667 and rs2480253, respectively), though neither was found in our sample of predominantly Caucasian DNAs. Our data do, however, offer a parallel to the pattern of variation in human PRNP. As assessed by genotyping the HGPD-CEPH repository, PRNP variation is dominated by a single common M129V polymorphism with an overall V129 allele frequency of 23% (rising to 65% V129 in American populations). The other polymorphisms are all rare, including E219K polymorphism (K219 1.3% overall, rising to 5.4% in Pacific populations), insertions and deletions in the octarepeat region (0.4%), plus a miscellany of silent substitutions (0.03%) and missense SNPs (142Ser and 232Arg totalling 0.03% alleles) [20]. Indeed, overall nucleotide diversity in human PRNP has been estimated at three times lower than an average derived from scrutiny of 245 other genes [20]. Standing in apparent contrast to these observations, ovine SPRN, like ovine PRNP, exhibited a number of coding sequence alterations. Insofar as three of the more common haplotypes a–g were absent from another study [17] our data may yet underestimate the full extent of diversity in SPRN, lending further support to the main conclusion of this paper. Parenthetically the trivial technical explanation that ovine SPRN variants defined here and by others derive from a pseudogene can be excluded because (i) current versions of the sheep genome do not provide evidence for such a pseudogene, and (ii) sequence variations described herein are all in-frame and lie within the context of a complete, contiguous ORF.

An unstable DNA tract in the ovine SPRN gene?

Variations in ovine SPRN are notable from the perspectives of the DNA sequence, and of the predicted chemical properties for the variant proteins. With regards to the former, while SNP variations require little comment, we defined three indel variations in addition to the wild type norm, all occurring in a 41-nucleotide tract that is comprised solely of G/C base-pairs. Because our analyses used replicate PCR reactions of starting genomic DNA, high fidelity polymerases, plus sequencing and restriction mapping of total PCR products, we can exclude that the polymorphisms reflect rare in vitro polymerase errors captured by molecular cloning. More likely, the polymorphisms reflect bona fide germ-line replication errors prompted by stable hairpin structures arising as a consequence of the extreme G+C content. The “+6nt” and “+9nt” alleles described here are trinucleotide expansion within alanine codons, while “-12nt” represents loss of a complete (Ala)3Gly unit (Figure 5B). In the case of trinucleotide repeat diseases, normal variation in a mean repeat size stands in contrast to unbridled instability (expansion) once a threshold size for a pre-mutation has been exceeded. For CAG trinucleotide repeat diseases the range of normal variation is from 4–19 to 6–44 repeat units rising to 10–33 and 39–82 repeats respectively for pathogenic alleles [21], but in the case of pure polyalanine tracts (below) the percent increase from a normal to pathogenic number ofrepeats may be smaller. At this stage we suggest that scrutiny of more sheep samples will reveal yet further size polymorphisms.

G+C content of SPRN hydrophobic tract residues: species differences

The ovine DNA coding sequence for the Sho hydrophobic domain encompasses a 41 nucleotide tract (42 nucleotides in the case of alleles encoding 71Ala) composed entirely of G+C base-pairs, yet in the nuclear genetic code alanine and glycine are each encoded by four codons, and can therefore include A or T residues in the third position. Indeed, alignment of sequences encoding the Sho hydrophobic domain from different mammals reveals usage of codons with A or T at the third position, with 1/41 (cattle), 3/41 (chimpanzee), 4/41 (humans), 6/41 (rhesus monkey) or 9/41 (mouse, rat) A or T nucleotides interposed into this tract. If this analysis is corrected to consider a shorter contiguous tract (starting at Ala 58 of the sheep sequence, as sheep and cows differ from most other mammals by a codon deletion, having a first repeat of Val(Ala)2Gly instead of Val(Ala)3Gly: Figure 5A) then these figures become 0/32 (cattle), 1/32 (chimpanzee), 2/32 (humans), 4/32 (rhesus monkey) or 8/32 (mouse, rat) A or T nucleotides interposed within a 32 nucleotide tract. Within this dataset of mammalian SPRN sequences, tracts of uninterrupted G+C base-pairs are a special feature of the ovine and bovine gene, perhaps contributing to species differences in the occurrence of hydrophobic domain coding sequence expansion and contraction. For trinucleotide-repeat motifs, the ability of individual DNA strands to form hairpin structures during replication and repair comprises a common postulate within all hypotheses to account for variations in unit length. High GC content determining melting temperature, as well as the inclusion of “hairpin-prone” CGG units in alanine tracts may thus predispose the central coding region of ovine SPRN to length variation [22].

Properties of Sho proteins with different hydrophobic domains

Hydrophobic region polymorphisms of ovine Sho protein are summarized in Figure 5B. While some of these polymorphisms involve conservative amino acid replacements (e.g. Ala71Val) and are documented in healthy (albeit young) animals, their phenotypic impact in aged or infected animals remains to be determined. The possibilities are that they could modulate prion infections, or in concert with other factors (e.g. greater degrees of genomic instability), might contribute to spontaneous prion disease in aged animals. In human PRNP, the widely-studied A117V mutation, and a variety of synthetic alanine to valine mutations at 4 other positions in the hydrophobic tract increase biogenesis of a transmembrane form of the protein (“CtmPrP”), and may be a cause of Gerstmann–Straussler Syndrome and neurodegenerative disease in transgenic mice, respectively [23]. In this vein, the human SPRN polymorphism T7M is now reported to be associated with sporadic CJD with a p value of 0.009 [19]. To the best of our knowledge the only mechanistic effect of PrP polymorphisms in the N-terminal signal peptide (described by Stewart et al for PrP L9R) is to alter the formation of the topological form called Ctm PrP [24], and interestingly this form involves embedding of the central hydrophobic tract into the plasma membrane. Perhaps a similar effect may explain how a human SPRN signal peptide polymorphism can alter some aspect of the pathogenesis of sporadic CJD.

Also worthy of consideration, there are connections between expansions in homopolymeric alanine and several neurodegenerative diseases. The first theme comprises trinucleotide expansions of genomic DNA. Here, typically occurring in alanine tracts of transcription factors, expansions above a normal range containing from as little as 1 residue to 10 extra alanine codons underlie at least 9 human conditions [25], [26]. Interestingly, the proteins with alanine expansions have a “gained” tendency to aggregate versus their wt counterparts [27], [28]. The second theme of note is a tendency for alanine-rich sequences to undergo α-helical to β structure transitions [29], [30], suggesting that structural studies of ovine Sho protein with wt and variant (Ala)3Gly repeat arrays may prove fruitful.

Parallel variation in Ovine SPRN and PRNP?

Diverse coding sequence variations in both ovine SPRN and PRNP raises the broader questions of origin, and the types of selection pressures that might operate on these genes. In terms of DNA replication mechanisms that might predispose to sequence variation, there is unlikely to be a single common theme: PRNP is characterised by missense mutations whereas SPRN is characterised by indel variation in a G/C rich tract as well as missense variation. With regards selection pressure, heterozygosity for the PRNP M129/V129 missense polymorphism (a genotype disfavouring prion replication) was attributed to a selective advantage against cannibalistic acquisition of prion infectivity in prehistoric humans [31]. However, others have raised the issue of ascertainment bias affecting this conclusion [32], [33]. For exposure to prion disease to shape PRNP allele frequency in susceptible populations, salient parameters will be the presence of a disease-related physiological deficit at the age when mating partners are selected, and exposure at an endemic level. Perhaps more plausibly, pressures to retain certain PRNP haplotypes (actually the common ARQ haplotype that is found to confer heightened susceptibility to common scrapie isolates, versus resistance-associated ARR or AHQ haplotypes of PRNP) may reflect selective advantages acting at the time of birth or during early postnatal life [8]. PrPC expression is increased during instances of brain trauma [34] and PrPC is associated with neuroprotective activity against a number of toxic compounds. Interestingly, in differentiated neuronal cultures, PrPC and Sho exert similar protective effects against a toxic stimulus [11]. Altered interactions with a common partner such as LPrP [35] deriving from selection for an altered form of PrP might in turn select for a compensatory allelic form of Sho. Another possibility is that common genetic variation in ovine SPRN driven by an unstable DNA tract will apply selection pressure for PrP variants with altered physiological activity to offset the action of the SPRN variants. However, as the dataset for genome wide variation in sheep (i.e. behaviour at other “control” loci) in sheep lags behind the situation in humans, and as the hypothetical LPrP protein waits to be identified, these possibilities must be considered as speculative for the time being.


Our studies define abundant coding sequence variation in the ovine SPRN gene. Allelic variants are analyzed by breed, and some approach a frequency of 20%. Most variation occurs in a hydrophobic tract encoded by 5 tandem repeats, and four alleles varying in this region engender stable proteins that may in turn determine different biological responses. Further studies on the transmission genetics of the SPRN indel alleles and the SPRN+PRNP genotypes of scrapie-challenged animals may be enlightening.

Author Contributions

Conceived and designed the experiments: ND DW. Performed the experiments: ND SW. Analyzed the data: ND. Contributed reagents/materials/analysis tools: ER AHF MH. Wrote the paper: ND DW.


  1. 1. Collinge J (2001) Prion diseases of humans and animals: their causes and molecular basis. Annu Rev Neurosci 24: 519–550.
  2. 2. Prusiner SB (1998) Prions. Proc Natl Acad Sci U S A 95: 13363–13383.
  3. 3. Palmer MS, Dryden AJ, Hughes JT, Collinge J (1991) Homozygous prion protein genotype predisposes to sporadic Creutzfeldt-Jakob disease. Nature 352: 340–342.
  4. 4. Goldmann W, Hunter N, Foster JD, Salbaum JM, Beyreuther K, et al. (1990) Two alleles of a neural protein gene linked to scrapie in sheep. Proc Natl Acad Sci USA 87: 2476–2480.
  5. 5. Laplanche JL, Chatelain J, Westaway D, Thomas S, Dussaucy M, et al. (1993) PrP polymorphisms associated with natural scrapie discovered by denaturing gradient gel electrophoresis. Genomics 15: 30–37.
  6. 6. Belt PB, Muileman IH, Schreuder BE, Bos-de Ruijter J, Gielkens AL, et al. (1995) Identification of five allelic variants of the sheep PrP gene and their association with natural scrapie. J Gen Virol 76 (Pt 3): 509–517.
  7. 7. Westaway D, Zuliani V, Cooper CM, Da Costa M, Neuman S, et al. (1994) Homozygosity for prion protein alleles encoding glutamine-171 renders sheep susceptible to natural scrapie. Genes Dev 8: 959–969.
  8. 8. Sawalha RM, Brotherstone S, Conington J, Villanueva B (2007) Lambs with scrapie susceptible genotypes have higher postnatal survival. PLoS ONE 2: e1236.
  9. 9. Premzl M, Sangiorgio L, Strumbo B, Marshall Graves JA, Simonic T, et al. (2003) Shadoo, a new protein highly conserved from fish to mammals and with similarity to prion protein. Gene 314: 89–102.
  10. 10. Shmerling D, Hegyi I, Fischer M, Blattler T, Brandner S, et al. (1998) Expression of amino-terminally truncated PrP in the mouse leading to ataxia and specific cerebellar lesions. Cell 93: 203–214.
  11. 11. Watts JC, Drisaldi B, Ng V, Yang J, Strome B, et al. (2007) The CNS glycoprotein Shadoo has PrP(C)-like protective properties and displays reduced levels in prion infections. Embo J 26: 4038–4050.
  12. 12. Drisaldi B, Coomaraswamy J, Mastrangelo P, Strome B, Yang J, et al. (2004) Genetic mapping of activity determinants within cellular prion proteins: N-terminal modules in PrPC offset pro-apoptotic activity of the doppel helix B/B' region. J Biol Chem.
  13. 13. Ferris SD, Sage RD, Prager EM, Ritte U, Wilson AC (1983) Mitochondrial DNA evolution in mice. Genetics 105: 681–721.
  14. 14. Premzl M, Gready JE, Jermiin LS, Simonic T, Marshall Graves JA (2004) Evolution of vertebrate genes related to Prion and Shadoo proteins - clues from comparative genomic analysis. Mol Biol Evol.
  15. 15. Lampo E, Van Poucke M, Hugot K, Hayes H, Van Zeveren A, et al. (2007) Characterization of the genomic region containing the Shadow of Prion Protein (SPRN) gene in sheep. BMC Genomics 8: 138.
  16. 16. Dickinson AG (1976) Scrapie in sheep and goats. In: Kimberlin RH, editor. Slow Virus Diseases of Animals and Man. Amsterdam: North-Holland Publishing. pp. 209–241.
  17. 17. Stewart P, Shen C, Zhao D, Goldmann W (2009) Genetic analysis of the SPRN gene in ruminants reveals polymorphisms in the alanine-rich segment of shadoo protein. J Gen Virol.
  18. 18. Lloyd SE, Grizenkova J, Pota H, Collinge J (2009) Shadoo (Sprn) and prion disease incubation time in mice. Mamm Genome.
  19. 19. Beck JA, Campbell T, Adamson G, Poulter M, Uphill J, et al. (2008) Association of a null allele of SPRN with variant Creutzfeldt-Jakob Disease. J Med Genet.
  20. 20. Soldevila M, Andres AM, Ramirez-Soriano A, Marques-Bonet T, Calafell F, et al. (2006) The prion protein gene in humans revisited: lessons from a worldwide resequencing study. Genome Res 16: 231–239.
  21. 21. Orr HT, Zoghbi HY (2007) Trinucleotide repeat disorders. Annu Rev Neurosci 30: 575–621.
  22. 22. Lenzmeier BA, Freudenreich CH (2003) Trinucleotide repeat instability: a hairpin curve at the crossroads of replication, recombination, and repair. Cytogenet Genome Res 100: 7–24.
  23. 23. Hegde RS, Mastrianni JA, Scott MR, DeFea KA, Trembaly P, et al. (1998) A Transmembrane Form of the Prion Protein in Neurodegenerative Disease. Science 279: 827–834.
  24. 24. Stewart RS, Harris DA (2003) Mutational analysis of topological determinants in prion protein (PrP) and measurement of transmembrane and cytosolic PrP during prion infection. J Biol Chem 278: 45960–45968.
  25. 25. Holter J, Carter D, Leresche N, Crunelli V, Vincent P (2005) A TASK3 channel (KCNK9) mutation in a genetic model of absence epilepsy. J Mol Neurosci 25: 37–51.
  26. 26. Albrecht A, Mundlos S (2005) The other trinucleotide repeat: polyalanine expansion disorders. Curr Opin Genet Dev 15: 285–293.
  27. 27. Calado A, Tome FM, Brais B, Rouleau GA, Kuhn U, et al. (2000) Nuclear inclusions in oculopharyngeal muscular dystrophy consist of poly(A) binding protein 2 aggregates which sequester poly(A) RNA. Hum Mol Genet 9: 2321–2328.
  28. 28. Caburet S, Demarez A, Moumne L, Fellous M, De Baere E, et al. (2004) A recurrent polyalanine expansion in the transcription factor FOXL2 induces extensive nuclear and cytoplasmic protein aggregation. J Med Genet 41: 932–936.
  29. 29. Ma B, Nussinov R (2002) Molecular dynamics simulations of alanine rich beta-sheet oligomers: Insight into amyloid formation. Protein Sci 11: 2335–2350.
  30. 30. Giri K, Bhattacharyya NP, Basak S (2007) pH-dependent self-assembly of polyalanine peptides. Biophys J 92: 293–302.
  31. 31. Mead S, Stumpf MP, Whitfield J, Beck JA, Poulter M, et al. (2003) Balancing selection at the prion protein gene consistent with prehistoric kurulike epidemics. Science 300: 640–643.
  32. 32. Kreitman M, Di Rienzo A (2004) Balancing claims for balancing selection. Trends Genet 20: 300–304.
  33. 33. Soldevila M, Calafell F, Helgason A, Stefansson K, Bertranpetit J (2005) Assessing the signatures of selection in PRNP from polymorphism data: results support Kreitman and Di Rienzo's opinion. Trends Genet 21: 389–391.
  34. 34. McLennan NF, Brennan PM, McNeill A, Davies I, Fotheringham A, et al. (2004) Prion protein accumulation and neuroprotection in hypoxic brain damage. Am J Pathol 165: 227–235.
  35. 35. Flechsig E, Manson JC, Barron R, Aguzzi A, Weissmann C (2004) Knockouts, Knockins, Transgenics and Transplants in Prion Research. In: Prusiner SB, editor. Prion Biology and Diseases. Second ed. Cold Spring Harbor, NY: Cold Spring Harbor Press. pp. 373–434.